Additionally, in comparison with primary prostate cancer, NK1R was highest in metastatic prostate cancer patients, accompanied with increasing expression of NE markers and NE-related genes (GSE3325) [30] (Fig. 2B). The gene discussed is TACR1; the disease is prostate carcinoma.